Anupam Rishi
YOU?
Author Swipe
View article: Clinical Outcomes for Extracranial Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Body Radiotherapy – Institutional Experience
Clinical Outcomes for Extracranial Oligometastatic Renal Cell Carcinoma Treated with Stereotactic Body Radiotherapy – Institutional Experience Open
View article: Neoadjuvant prostate artery embolization prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiation
Neoadjuvant prostate artery embolization prior to prostate radiation therapy: A single institution experience on the durability of clinical urinary improvement after radiation Open
View article: Intricacies of human–AI interaction in dynamic decision-making for precision oncology
Intricacies of human–AI interaction in dynamic decision-making for precision oncology Open
View article: Revisiting Variable Stars Near Globular Clusters South of −29° Declination
Revisiting Variable Stars Near Globular Clusters South of −29° Declination Open
We review an often‐cited but seldom‐accessed catalogue by Fourcade and Laborde (1966) of 785 variable stars near 47 southern Galactic globular clusters, and recover the locations of 85 stars that were not incorporated into subsequent varia…
View article: Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion
Prostate Artery Embolization in the Setting of Prostate Cancer: Review and Opinion Open
Prostate Artery Embolization (PAE) is a novel minimally invasive angiographic technique that has been used effectively to treat men with lower urinary tract symptoms (LUTS) from benign prostatic hyperplasia (BPH). However, applications of …
View article: Intricacies of Human-AI Interaction in Dynamic Decision-Making for Precision Oncology: A Case Study in Response-Adaptive Radiotherapy
Intricacies of Human-AI Interaction in Dynamic Decision-Making for Precision Oncology: A Case Study in Response-Adaptive Radiotherapy Open
Background Adaptive treatment strategies that can dynamically react to individual cancer progression can provide effective personalized care. Longitudinal multi-omics information, paired with an artificially intelligent clinical decision s…
View article: Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy
Clinical Outcomes of Prostate SBRT Using Non-adaptive MR-Guided Radiotherapy Open
Objectives Stereotactic body radiotherapy (SBRT) is widely used for localized prostate cancer and implementation of MR-guided radiotherapy has the advantage of tighter margins and improved sparing of organs at risk. Here we evaluate outcom…
View article: Table of Contents
Table of Contents Open
View article: Cytoreductive Stereotactic Body Radiotherapy with Tyrosine Kinase Inhibitors for Intrathoracic Oligoprogressive EGFR-mutated Lung Cancer
Cytoreductive Stereotactic Body Radiotherapy with Tyrosine Kinase Inhibitors for Intrathoracic Oligoprogressive EGFR-mutated Lung Cancer Open
Background: Epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC) shows an impressive initial response to EGFR tyrosine kinase inhibitors (EGFR-TKI). However, resistance invariably develops, commonly involving …
View article: Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study
Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study Open
View article: FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation
FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation Open
View article: Abstracts From the NCCN 2021 Virtual Annual Conference
Abstracts From the NCCN 2021 Virtual Annual Conference Open
Background: There are no existing quality measures to define optimal end-of-life care (EOLC) for children with cancer, contributing to high healthcare utilization and variable palliative care provision.In a preceding study, we developed a …
View article: Proliferation Saturation Index to Characterize Response to Radiation Therapy and Evaluate Altered Fractionation in Head and Neck Cancer
Proliferation Saturation Index to Characterize Response to Radiation Therapy and Evaluate Altered Fractionation in Head and Neck Cancer Open
View article: Pretreatment CT and PET Radiomics Predicting Rectal Cancer Patients in Response to Neoadjuvant Chemoradiotherapy
Pretreatment CT and PET Radiomics Predicting Rectal Cancer Patients in Response to Neoadjuvant Chemoradiotherapy Open
The pre-treatment composite radiomics signatures were highly predictive of pathological response in rectal cancer treated with NACR T. A larger cohort is warranted for further validation.
View article: TAMI-54. THE PRESENCE OF IMMUNE CELL INFILTRATES IN THE TISSUE MICROENVIRONMENT OF HIGH-GRADE GLIOMAS AND THEIR ASSOCIATION WITH OVERALL SURVIVAL
TAMI-54. THE PRESENCE OF IMMUNE CELL INFILTRATES IN THE TISSUE MICROENVIRONMENT OF HIGH-GRADE GLIOMAS AND THEIR ASSOCIATION WITH OVERALL SURVIVAL Open
OBJECTIVE Tumor-associated microglia and macrophages (TAMs) influence brain tumor biology and promote tumor-proliferating phenotype. Studies have shown these cell types predict outcomes in various tumor sites with limited evidence in high-…
View article: Efficacy and Safety of Stereotactic Body Radiotherapy for Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients at a High-Volume Center
Efficacy and Safety of Stereotactic Body Radiotherapy for Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients at a High-Volume Center Open
View article: Yttrium-90 Glass Microsphere Transarterial Radioembolization for Patients with Unresectable Liver-Dominant Breast Cancer Metastasis
Yttrium-90 Glass Microsphere Transarterial Radioembolization for Patients with Unresectable Liver-Dominant Breast Cancer Metastasis Open
View article: Liver-directed treatments of liver-dominant metastatic leiomyosarcoma
Liver-directed treatments of liver-dominant metastatic leiomyosarcoma Open
Treatment with liver-directed therapies for patients with unresectable metastatic leiomyosarcoma to the liver is safe and can improve overall survival, with OS after liver-directed therapy being similar to patients who underwent surgical r…
View article: 4:21 PM Abstract No. 246 Transarterial Y90 radioembolization of liver metastases from breast cancer
4:21 PM Abstract No. 246 Transarterial Y90 radioembolization of liver metastases from breast cancer Open
View article: Overcoming non-small cell lung cancer radiation resistance by modulating the tumor-immune ecosystem
Overcoming non-small cell lung cancer radiation resistance by modulating the tumor-immune ecosystem Open
Non-small-cell lung cancer is the leading cause of cancer death worldwide. Although radiotherapy is an effective treatment choice for early-stage cases, the 5-year survival rate of patients diagnosed in late-stages remains poor. Increasing…
View article: Clinical Outcome and Late Toxicity following Definitive Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma of the Vulva
Clinical Outcome and Late Toxicity following Definitive Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma of the Vulva Open
View article: Abstract No. 693 Transarterial chemoembolization treatment of liver-dominant metastatic leiomyosarcoma
Abstract No. 693 Transarterial chemoembolization treatment of liver-dominant metastatic leiomyosarcoma Open
View article: Mathematical Model of Head and Neck Cancer Response to Predict Fractionation Schema for Robust Responses During Radiation Therapy
Mathematical Model of Head and Neck Cancer Response to Predict Fractionation Schema for Robust Responses During Radiation Therapy Open
View article: Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis
Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis Open
View article: The future of personalised radiotherapy for head and neck cancer
The future of personalised radiotherapy for head and neck cancer Open
View article: Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma
Radiotherapy Characteristics and Outcomes for Head and Neck Carcinoma of Unknown Primary vs T1 Base-of-Tongue Carcinoma Open
Intensity-modulated radiotherapy for CUP site or T1-category BOT carcinoma had similar clinical outcomes. Identifying hidden BOT primary carcinoma with novel approaches (eg, transoral robotic surgery and transoral laser microsurgery) may l…
View article: 93: Outcome of Radiotherapy for Aggressive forms of Basal Cell Carcinoma of the Head and Neck
93: Outcome of Radiotherapy for Aggressive forms of Basal Cell Carcinoma of the Head and Neck Open
View article: Clinical Outcome and Distinct Molecular Characterization of Pediatric Glioblastoma: Analysis of 66 Patients Treated With Postoperative Focal Radiation Therapy With Concurrent and Adjuvant Temozolomide
Clinical Outcome and Distinct Molecular Characterization of Pediatric Glioblastoma: Analysis of 66 Patients Treated With Postoperative Focal Radiation Therapy With Concurrent and Adjuvant Temozolomide Open
View article: Clinical outcome and molecular characterization of pediatric glioblastoma treated with postoperative radiotherapy with concurrent and adjuvant temozolomide: a single institutional study of 66 children
Clinical outcome and molecular characterization of pediatric glioblastoma treated with postoperative radiotherapy with concurrent and adjuvant temozolomide: a single institutional study of 66 children Open
Background Glioblastoma (GBM) in children is rare. Pediatric GBM have a distinct molecular profile as compared to adult GBM. There are relatively few studies of pediatric GBMs and no standard of care on adjuvant therapy. We aimed to evalua…